Schizophrenia Drug Reduces Tau Protein Aggregation in Cell and Mouse Models, Study Finds
Amisulpride, an antipsychotic drug, is capable of reducing aggregation of the tau protein in cell and mouse models, according to a study published earlier this year. While the drug could…
Read MoreDuke Caregiver Community Event — September 7, 2023
AFTD Ambassador Jerry Lazarus and former AFTD Board member and support group facilitator Paul Lester will be hosting an AFTD exhibitor table at the Duke Caregiver Community Event in Durham,…
Read MoreDuke Caregiver Community Event
AFTD Ambassador Jerry Lazarus and former AFTD Board member and support group facilitator Paul Lester will be hosting an AFTD exhibitor table at the Duke Caregiver Community Event in Durham,…
Read MoreAdvancing Hope: AFTD’s Director of Research Engagement Attends Cure VCP Conference
Shana Dodge, PhD, AFTD’s Director of Research Engagement, spoke at the 2023 Cure VCP Connections Conference, held July 20-22 in Las Vegas. VCP disease, also called VCP-associated multisystem proteinopathy or…
Read MoreGuest Feature: That Picture, That Movie, That Song – Connecting with My Dad Beyond FTD
FTD can distort one’s personality and behavior in unpredictable and upsetting ways, and it can be hard to remember who they were. But often, the “true” self of the person…
Read MoreAFTD Webinar: Genetic FTD — To Test or Not to Test
The decision to learn one’s own genetic risk for developing FTD is highly personal. An individual’s test results may reveal information not only about their own status, but may shed…
Read More